ZURICH (Reuters) - The investment vehicle of the Sandoz family will get 2.6 billion Swiss francs ($2.90 billion) from selling a chunk of Swiss pharma giant Novartis, the bookrunner on the deal said on ...
© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...
Hosted on MSN1mon
New evidence allowed in brazen Jersey Shore polluter case. Site considered one of worst in U.S.Nonprofit Save Barnegat Bay and Toms River officials have long challenged a proposed $500,000 settlement between the state of New Jersey and BASF, which took over Ciba-Geigy and is blamed for ...
Novartis AG’s Sandoz family sold a roughly 1.2% stake in the Swiss pharmaceutical group for 2.6 billion Swiss francs ($2.9 ...
However its roots go a long way back: it was created through the merger of two top Swiss companies, Ciba-Geigy and Sandoz Laboratories, in what some say has been the "most successful pharma merger".
Die Sandoz-Familienstiftung will laut einem Bericht der Nachrichtenagentur Reuters ein bedeutendes Paket ihrer Aktien des Pharmakonzerns Novartis veräussern. Sie bietet nun über ihre ...
Die Sandoz-Familienstiftung, der zweitgrößte Aktionär des Pharmakonzerns Novartis, hat angekündigt, ein bedeutendes ...
Ciba Specialty Chemicals (India) Limited (`the Company') was formed as a part of the international demerger of the specialty chemicals business from Ciba-Geigy Limited, Switzerland. The Honorable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback